Thrombophilic state in cancer, Part I: Biology, incidence, and risk factors

Authors

  • Peter J. DiPasco MD,

    1. Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida
    Search for more papers by this author
    • Fellow in Surgical Oncology.

  • Subhasis Misra MD,

    1. Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida
    Search for more papers by this author
    • Fellow in Surgical Oncology.

  • Leonidas G. Koniaris MD,

    1. Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida
    Search for more papers by this author
    • Associate Professor of Surgery.

  • Frederick L. Moffat Jr. MD, MBA

    Corresponding author
    1. Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida
    • Sylvester Comprehensive Cancer Center, Surgical Oncology, 310T 1475 NW 12th Ave, Suite 3550 Miami, FL 33136. Fax: 305-243-4907.
    Search for more papers by this author
    • Professor of Surgery.


Abstract

The association between malignancy and thrombosis has long been appreciated but remains incompletely understood. This is the first of a two-part review of the complex, integral relationship between these two entities, and addresses the mechanisms and pathogenesis of this relationship and the clinical risk factors for thromboembolism in cancer patients. J. Surg. Oncol. 2011; 104:316–322. © 2011 Wiley-Liss, Inc.

Ancillary